| Divis Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532488 |
NSE Symbol : DIVISLAB |
P/E(TTM) : 84.46 |
|
ISIN Demat : INE361B01024 |
Div & Yield% : 0.51 |
EPS(TTM) : 69.20 |
|
Book Value(₹) : 513.62 |
Market Cap(₹Cr) : 155,159.75 |
Face Value(₹) : 2.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 | 5,310.57 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 | 5,310.57 |
| Other Income | 337.00 | 349.00 | 111.26 | 62.53 | 189.86 |
| Stock Adjustments | 127.00 | -50.00 | 449.99 | 100.00 | 94.10 |
| Total Income | 8,129.00 | 7,924.00 | 9,441.07 | 6,961.14 | 5,594.53 |
| EXPENDITURE : | |||||
| Raw Materials | 3,270.00 | 3,035.00 | 3,499.18 | 2,416.47 | 2,223.95 |
| Power and Fuel Cost | 477.00 | 496.00 | 390.05 | 319.15 | 280.73 |
| Other Manufacturing Expenses | 299.00 | 285.00 | 255.38 | 202.29 | 184.36 |
| Selling and Administration Expenses | 367.00 | 402.00 | 340.16 | 292.53 | 222.86 |
| Miscellaneous Expenses | 137.00 | 55.00 | 40.95 | 37.69 | 68.00 |
| Employee Benefit Expenses | 1,067.00 | 953.00 | 926.55 | 808.68 | 608.36 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 2,512.00 | 2,698.00 | 3,988.80 | 2,884.33 | 2,006.27 |
| Interest | 4.00 | 2.00 | 1.73 | 1.81 | 7.03 |
| Gross Profit | 2,508.00 | 2,696.00 | 3,987.07 | 2,882.52 | 1,999.24 |
| Depreciation | 376.00 | 342.00 | 310.55 | 254.65 | 185.95 |
| Profit Before Tax | 2,132.00 | 2,354.00 | 3,676.52 | 2,627.87 | 1,813.29 |
| Current Tax | 511.00 | 438.00 | 637.20 | 609.05 | 387.79 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 45.00 | 108.00 | 90.78 | 64.10 | 52.79 |
| Reported Net Profit | 1,576.00 | 1,808.00 | 2,948.54 | 1,954.72 | 1,372.71 |
| Extraordinary Items | 0.74 | 3.07 | -1.65 | -2.45 | 41.46 |
| Adjusted Net Profit | 1,575.26 | 1,804.93 | 2,950.19 | 1,957.17 | 1,331.25 |
| Adjustment below Net Profit | -1.00 | 2.00 | 2.18 | 0.16 | -92.52 |
| Profit/Loss Balance carried down | 10,922.00 | 9,967.00 | 7,588.31 | 5,814.44 | 5,636.87 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 772.00 | 855.00 | 571.50 | 181.01 | 1,102.62 |
| P & L Balance carried down | 11,725.00 | 10,922.00 | 9,967.53 | 7,588.31 | 5,814.44 |
| Dividend | - | - | - | - | 424.75 |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 1,500.00 | 1,500.00 | 1,500.00 | 1,000.00 | 800.00 |
| Dividend Per Share(Rs) | 30.00 | 30.00 | 30.00 | 20.00 | 16.00 |
| Earnings Per Share-Unit Curr | 59.47 | 68.23 | 111.08 | 73.64 | 51.71 |
| Earnings Per Share(Adj)-Unit Curr | 59.47 | 68.23 | 111.08 | 73.64 | 51.71 |
| Book Value | 508.83 | 479.43 | 440.44 | 349.28 | 275.63 |
| Book Value(Adj)-Unit Curr | 508.83 | 479.43 | 440.44 | 349.28 | 275.63 |